Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge.

controls, which were higher than those recovered from mice administered BCG i.v., although this did not reach statistical significance in the case of the TCID 50 assay ( Fig. 2 D ).

also in 111,027 other papers